Bevacizumab is a targeted drug treatment for advanced cervical cancer. It aims to help control the cancer and any symptoms. It is also known as the brand name Avastin.
We know that being diagnosed with advanced cervical cancer can be overwhelming – we are here to support you and help make sense of things. We have a lot of support services that you might find helpful, including a free Helpline on 0808 802 8000.
On this page:
- What is Avastin? >
- Who can have Avastin? >
- Making decisions about treatment >
- Before Avastin >
- During Avastin >
- After Avastin >
- Risks and side effects of Avastin >
- More information and support >
What is Avastin (bevacizumab)?
Avastin is called a targeted drug. This is because it targets a part of the cancer cell called vascular endothelial growth factor (VEGF). VEGF helps cells make blood vessels, which they need to grow. By targeting this part of the cancer cell, Avastin makes sure the cancer can’t grow.
Bevacizumab needs to be given alongside chemotherapy for it to control cervical cancer. You will normally have it with a combination of chemotherapy drugs:
- paclitaxel and cisplatin or carboplatin
- paclitaxel and topotecan
Read about chemotherapy for cervical cancer >
Who can have Avastin (bevacizumab)?
You may be able to have Avastin if you have:
- cancer that has spread to other parts of the body (metastatic)
- cancer that has come back after other treatments (recurrent)
- cancer that does not respond to treatment (persistent).
You need to have Avastin with chemotherapy, so your healthcare team will check you are well enough to cope with any side effects of these treatments.
Availability of Avastin
As of June 2022, Avastin is now available to treat advanced cervical cancer in all nations of the UK.